Prognostic Value and Optimal Sampling Time of S-100B Protein for Outcome Prediction in Cardiac Arrest Patients Treated with Therapeutic Hypothermia
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The aim of this study was to determine the prognostic value and optimal sampling time of serum S-100B protein for the prediction of poor neurological outcomes in post-cardiac arrest (CA) patients treated with therapeutic hypothermia (TH). Methods: We prospectively measured serum S100 calcium binding protein beta subunit (S-100B protein) levels 12 times (0-96 hours) after the return of spontaneous circulation (ROSC). The patients were classified into two groups based on cerebral performance category (CPC): the good neurological outcome group (CPC 1-2 at 6 months) and the poor neurological outcome group (CPC 3-5). We compared serial changes and serum S-100B protein levels at each time point between the two groups and performed receiver operating characteristic curve analysis for the prediction of poor neurological outcomes. Results: A total of 40 patients were enrolled in the study. S-100B protein levels peaked at ROSC (0 hour), decreased rapidly to 6 hours and maintained a similar level thereafter. Serum S-100B protein levels in the poor CPC group (n = 22) were significantly higher than in the good CPC group (n = 18) at all time points after ROSC except at 4 hours. The time points with highest area under curve were 24 (0.829) and 36 (0.837) hours. The cut-off value, the sensitivity (24/36 hours) and specificity (24/36 hours) for the prediction of poor CPC at 24 and 48 hours were 0.221/0.249 ug/L, 75/65% and 82.4/94.1%, respectively. Conclusions: Serum S-100B protein was an early and useful marker for the prediction of poor neurological outcomes in post-CA patients treated with TH and the optimal sampling times were 24 and 36 hours after ROSC.
Abstract
Background: The aim of this study was to determine the prognostic value and optimal sampling time of serum S-100B protein for the prediction of poor neurological outcomes in post-cardiac arrest (CA) patients treated with therapeutic hypothermia (TH). Methods: We prospectively measured serum S100 calcium binding protein beta subunit (S-100B protein) levels 12 times (0-96 hours) after the return of spontaneous circulation (ROSC). The patients were classified into two groups based on cerebral performance category (CPC): the good neurological outcome group (CPC 1-2 at 6 months) and the poor neurological outcome group (CPC 3-5). We compared serial changes and serum S-100B protein levels at each time point between the two groups and performed receiver operating characteristic curve analysis for the prediction of poor neurological outcomes. Results: A total of 40 patients were enrolled in the study. S-100B protein levels peaked at ROSC (0 hour), decreased rapidly to 6 hours and maintained a similar level thereafter. Serum S-100B protein levels in the poor CPC group (n = 22) were significantly higher than in the good CPC group (n = 18) at all time points after ROSC except at 4 hours. The time points with highest area under curve were 24 (0.829) and 36 (0.837) hours. The cut-off value, the sensitivity (24/36 hours) and specificity (24/36 hours) for the prediction of poor CPC at 24 and 48 hours were 0.221/0.249 ug/L, 75/65% and 82.4/94.1%, respectively. Conclusions: Serum S-100B protein was an early and useful marker for the prediction of poor neurological outcomes in post-CA patients treated with TH and the optimal sampling times were 24 and 36 hours after ROSC.
참고문헌 (24)
- Sasson C, "Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis", Circ Cardiovasc Qual Outcomes, 3, pp.63~81 (2010)
- Nolan JP, "Outcome following admission to UK intensive care units after cardiac arrest: a secondary analysis of the ICNARC case mix programme database", Anaesthesia, 62, pp.1207~1216 (2007)
- 이명갑, "비외상성 병원전 심정지 환자의 심폐소생술 결과", 대한응급의학회지, 13(4), pp.428~433 (2002), 대한응급의학회
- 김성은, "일개 3차 의료기관에 내원한 병원전 심정지 환자의 심폐소생술 결과", 대한응급의학회지, 16(5), pp.495~504 (2005), 대한응급의학회
- 박규남, "심폐 소생술 후 저산소성 허혈성 혼수 환자의 임상적 경과", 대한응급의학회지, 16(3), pp.327~333 (2005), 대한응급의학회
- Nolan JP, "Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a scientific statement from the international liaison committee on resuscitation;the American heart association emergency cardiovascular care committee; the council on cardiovascular surgery and anesthesia; the council on cardiopulmonary, perioperative, and critical care; the council on clinical cardiology;the council on stroke", Resuscitation, 79, pp.350~379 (2008)
- Madl C, "Early prediction of individual outcome after cardiopulmonary resuscitation", Lancet, 341, pp.855~858 (1993)
- Hypothermia after Cardiac Arrest Study Group, "Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest", N Engl J Med, 346, pp.549~556 (2002)
- Bernard SA, "Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia", N Engl J Med, 346, pp.557~563 (2002)
- Wijdicks EF, "Quality Standards Subcommittee of the American Academy of Neurology: Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology", Neurology, 67, pp.203~210 (2006)
- Tiainen M, "Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia", Stroke, 34, pp.2881~2886 (2003)
- Hachimi-Idrissi S, "The evolution of serum astroglial S-100 beta protein in patients with cardiac arrest treated with mild hypothermia", Resuscitation, 64, pp.187~192 (2005)
- Derwall M, "Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study", Crit Care, 13, pp.R58~ (2009)
- Rundgren M, "Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia", Resuscitation, 80, pp.784~789 (2009)
- Wennervirta JE, "Hypothermia-treated cardiac arrest patients with good neurological outcome differ early in quantitative variables of EEG suppression and epileptiform activity", Crit Care Med, 37, pp.2427~2435 (2009)
- Mörtberg E, "S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment", Resuscitation, 82, pp.26~31 (2011)
- Stammet P, "Modeling serum level of S-100β and bispectral index to predict outcome after cardiac arrest", J Am Coll Cardiol, 62, pp.851~858 (2013)
- Zellner T, "NSE and S-100B are not sufficiently predictive of neurologic outcome after therapeutic hypothermia for cardiac arrest", Resuscitation, 84, pp.1382~1386 (2013)
- Gray WA, "Unsuccessful emergency medical resuscitation--are continued efforts in the emergency department justified?", N Engl J Med, 325, pp.1393~1398 (1991)
- Hamel MB, "Cost effectiveness of aggressive care for patients with nontraumatic coma", Crit Care Med, 30, pp.1191~1196 (2002)
- Geocadin RG, "Neurologic prognosis and withdrawal of life support after resuscitation from cardiac arrest", Neurology, 67, pp.105~108 (2006)
- Booth CM, "Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest", JAMA, 291, pp.870~879 (2004)
- Schäfer BW, "The S100 family of EF-hand calcium-binding proteins: functions and pathology", Trends Biochem Sci, 21, pp.134~140 (1996)
- Heizmann CW, "S100 proteins: structure, functions and pathology", Front Biosci, 7, pp.d1356~d1368 (2002)
